compared to the commercially available drug (by the Mechnikov Institute for Vaccine and Serum Research).
A vaccine-usable strain (ERA-CB 20M) of fixed rabies has been obtained (by the Ivanovsky Institute of Virology in collaboration with the Narvak Stock Company).
The following vaccines have been created:
HIV/AIDS vaccine based on the genetically-engineered drug Vichrepol (by the Ivanovsky Institute of Virology in collaboration with the Institute of Immunology of the Russian Ministry of Health)
combined mumps-measles vaccine (by the Andzhaparidze Institute for Viral Drug Research)
multi-component vaccine from conditionally pathogenic bacteria for prophylaxis of acute respiratory infections of non-influenza nature (by the Mechnikov Institute for Vaccine and Serum Research)
A highly-specific serum for diagnostics of staphylococcus has been obtained.
SOURCE: Ministry of Health (2003).
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Appendix M Test Systems and Other Products Being Developed in Russian Laboratories ."
Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security . Washington, DC: The National Academies Press,
Please select a format: